Literature DB >> 24829628

Intravenous drug abuse and tricuspid valve endocarditis: Growing trends in the Middle East Gulf region.

Prashanth Panduranga1, Seif Al-Abri1, Jawad Al-Lawati1.   

Abstract

Traditionally, tricuspid valve endocarditis is uncommon in the Middle East region. However, recent global data indicate growing trends in the use of illicit drug abuse, specifically injectable heroin, in the Middle East Gulf region. The presence of many transit port services in the Middle East Gulf States has led to smuggling of substance abuse drugs in the region. The Middle East Gulf States, currently a transit market, are also becoming a growing consumer market in view of the increased substance abuse in the youth. However, there is a paucity of data with respect to the prevalence or incidence of tricuspid valve endocarditis in the region, probably due to underdiagnosis or underreporting. A high index of suspicion of tricuspid valve endocarditis is essential in patients with a history of intravenous drug abuse. This article reviews the epidemiology of illicit drug abuse in the Middle East Gulf region, as well as the diagnosis and treatment of tricuspid valve endocarditis, and calls for all physicians in the region to be vigilant while dealing with intravenous drug abuse.

Entities:  

Keywords:  Drug abuser; Illicit drugs; Infective endocarditis; Middle East; Tricuspid valve

Year:  2013        PMID: 24829628      PMCID: PMC4017343          DOI: 10.4330/wjc.v5.i11.397

Source DB:  PubMed          Journal:  World J Cardiol


  44 in total

Review 1.  Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis.

Authors:  J A Frontera; J D Gradon
Journal:  Clin Infect Dis       Date:  2000-02       Impact factor: 9.079

Review 2.  Injection drug use and right sided endocarditis.

Authors:  Rob Moss; Brad Munt
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

Review 3.  Antimicrobials for right-sided endocarditis in intravenous drug users: a systematic review.

Authors:  Derek Yung; Dan Kottachchi; Binod Neupane; Shariq Haider; Mark Loeb
Journal:  J Antimicrob Chemother       Date:  2007-09-19       Impact factor: 5.790

4.  Long-term outcome for the surgical treatment of infective endocarditis with a focus on intravenous drug users.

Authors:  David G Rabkin; Nahush A Mokadam; Donald W Miller; Raymond R Goetz; Edward D Verrier; Gabriel S Aldea
Journal:  Ann Thorac Surg       Date:  2011-11-04       Impact factor: 4.330

5.  Long-term outcomes in valve replacement surgery for infective endocarditis.

Authors:  Scott P Kaiser; Spencer J Melby; Andreas Zierer; Richard B Schuessler; Marc R Moon; Nader Moazami; Michael K Pasque; Charles Huddleston; Ralph J Damiano; Jennifer S Lawton
Journal:  Ann Thorac Surg       Date:  2007-01       Impact factor: 4.330

6.  Infective endocarditis: a prospective study of 60 consecutive cases.

Authors:  Y A Kiwan; N Hayat; D G Vijayaraghavan; T Das Chugh; N Khan; F Mualla; S Madi
Journal:  Mater Med Pol       Date:  1990 Jul-Sep

7.  Clinical features and outcome of infective endocarditis in yemeni patients treated with empirical antibiotic therapy.

Authors:  Al-Aghbari Khaled; Alezzy Yahya Al-Noami; Mohamed Al-Ansi; Ahmed Askar Faiza
Journal:  Heart Views       Date:  2010-03

8.  Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study.

Authors:  David R Murdoch; G Ralph Corey; Bruno Hoen; José M Miró; Vance G Fowler; Arnold S Bayer; Adolf W Karchmer; Lars Olaison; Paul A Pappas; Philippe Moreillon; Stephen T Chambers; Vivian H Chu; Vicenç Falcó; David J Holland; Philip Jones; John L Klein; Nigel J Raymond; Kerry M Read; Marie Francoise Tripodi; Riccardo Utili; Andrew Wang; Christopher W Woods; Christopher H Cabell
Journal:  Arch Intern Med       Date:  2009-03-09

9.  Changing profile of infective endocarditis: results of a 1-year survey in France.

Authors:  Bruno Hoen; François Alla; Christine Selton-Suty; Isabelle Béguinot; Anne Bouvet; Serge Briançon; Jean-Paul Casalta; Nicolas Danchin; François Delahaye; Jerome Etienne; Vincent Le Moing; Catherine Leport; Jean-Luc Mainardi; Raymond Ruimy; François Vandenesch
Journal:  JAMA       Date:  2002-07-03       Impact factor: 56.272

Review 10.  Staphylococcus aureus infections in injection drug users: risk factors and prevention strategies.

Authors:  S Bassetti; M Battegay
Journal:  Infection       Date:  2004-06       Impact factor: 3.553

View more
  2 in total

1.  Successful treatment of acute renal failure secondary to complicated infective endocarditis by peritoneal dialysis: a case report.

Authors:  Aisha M Al-Osail; Ibrahim M Al-Zahrani; Abdullah A Al-Abdulwahab; Sarah M Alhajri; Emad M Al-Osail; Abdullah K Al-Hwiesh; Fahad A Al-Muhanna
Journal:  BMC Res Notes       Date:  2017-09-07

2.  The characteristics and patterns of utilization of healthcare services among Omanis with substance use disorders attending therapy for cessation.

Authors:  Nabila Al Wahaibi; Anwaar Al Lawati; Falaah Al Ruqeishy; Abdulla Al Khatri; Yahya Al-Farsi; Tahira M A Juma; Fatma Al Hinai; Nasser Al-Sibani; Sangeetha Mahadevan; Samir Al-Adawi
Journal:  PLoS One       Date:  2019-01-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.